Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-9zx9hy2Completed
Randomised, triple-blind trial of atropine in hypersalivation (2 arms), sponsored by Universidade Estadual de Ponta Grossa. Primary endpoint: Salivary flow. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-9zx9hy2.